| abstract |
The present invention relates to regulation ' the IQ die bodys containing the gtpase activating protein ' expression of (IQGAP) and/or the ASON of function, especially, the natural antisense polynucleotides of targeting ' the IQ die bodys containing gtpase activating protein ' (IQGAP) are passed through.The invention further relates to the identification of these ASONs and their purposes in the related disease and illness of IQGAP expression is treated. |